NASDAQ:LUXA

Lux Health Tech Acquisition Stock Forecast, Price & News

$10.23
-0.04 (-0.39 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.17
Now: $10.23
$10.48
50-Day Range
$10.10
MA: $10.52
$11.50
52-Week Range
$10.05
Now: $10.23
$13.27
Volume125,867 shs
Average Volume289,280 shs
Market Capitalization$441.17 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Lux Health Tech Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Industry, Sector and Symbol

Industry Shell Companies
Sub-IndustryN/A
Current SymbolNASDAQ:LUXA
CUSIPN/A
CIKN/A
Phone646-475-4385
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$441.17 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Unclassified Sector

219th out of 243 stocks

Shell Companies Industry

239th out of 418 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$10.23
-0.04 (-0.39 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LUXA News and Ratings via Email

Sign-up to receive the latest news and ratings for LUXA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Lux Health Tech Acquisition (NASDAQ:LUXA) Frequently Asked Questions

What stocks does MarketBeat like better than Lux Health Tech Acquisition?

Wall Street analysts have given Lux Health Tech Acquisition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Lux Health Tech Acquisition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Lux Health Tech Acquisition?

Lux Health Tech Acquisition saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 147,400 shares, a decline of 40.8% from the March 15th total of 249,000 shares. Based on an average daily volume of 310,300 shares, the short-interest ratio is presently 0.5 days.
View Lux Health Tech Acquisition's Short Interest
.

Who are Lux Health Tech Acquisition's key executives?

Lux Health Tech Acquisition's management team includes the following people:
  • Mr. Joshua Defonzo, CEO & Director (Age 40)
  • Ms. Segolene Scarborough, CFO & Treasurer (Age 41)

Who are some of Lux Health Tech Acquisition's key competitors?

What is Lux Health Tech Acquisition's stock symbol?

Lux Health Tech Acquisition trades on the NASDAQ under the ticker symbol "LUXA."

How do I buy shares of Lux Health Tech Acquisition?

Shares of LUXA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lux Health Tech Acquisition's stock price today?

One share of LUXA stock can currently be purchased for approximately $10.23.

How much money does Lux Health Tech Acquisition make?

Lux Health Tech Acquisition has a market capitalization of $441.17 million.

What is Lux Health Tech Acquisition's official website?

The official website for Lux Health Tech Acquisition is www.luxhealth.tech.

How can I contact Lux Health Tech Acquisition?

The company can be reached via phone at 646-475-4385.


This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.